Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy
D. Fuster et al., Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy, TRANSPLAN I, 13(5), 2000, pp. 327-332
This study was performed to determine the value of dipyridamole-Tc-99m-meth
oxy-isobutyl isonitrile perfusion ((TC)-T-99m-MIBI) tomographic scintigraph
y in the assessment of cardiac risk in patients being evaluated prior to co
mbined pancreas-kidney transplantation (PKT). We performed perfusion tomogr
aphic scintigraphy using single photon emission computed tomography (SPECT)
on 77 patients. The tomographic images did not show clinically relevant fi
ndings in 65 patients In the remaining 12 patients, coronary arteriography
was performed: 2 showed normal results, 4 showed no stenosis, and 6 showed
significant stenosis (greater than or equal to 70 %). Seventy-two patients
underwent PKT. During the follow-up (6-48 months), there were seven cardiac
events, 4 patients with significant stenosis, and 3 with nonsignificant st
enosis upon coronary arteriography, and all had pathological tomographic im
ages. Tc-99m-MIBI tomographic scintigraphy may be useful in identifying pat
ients at low risk of incurring cardiac events after PKT and may, in a large
group of patients, obviate the need for routine coronary angiography.